The editor -in -chief of this creation must "find a bunch of reliable people and do a valuable thing"

Text ｜ "China Science News" reporter Zhang Siwei

Ding Siyue

Not long ago, the world's first venous hypertension and liver cirrhosis journal Portal Hypertension Cirrhosis was successfully launched.

Qi Xiaolong, the assistant to the dean of the Zhongda University Hospital of Southeast University and the director of the Gate vein high pressure center, as the editor -in -chief of the journal, leads a first -class The expert team of higher education institutions builds a world -class door vein high -pressure academic highland.

Qi Xiaolong interviewee confession

"Cheats" behind Xueba

Qi Xiaolong is a native of Lanzhou. In 2004, Qi Xiaolong was admitted to the middle school entrance examination of Lanzhou No. 2 Middle School. During the college entrance examination in 2007, he was admitted to the direct blog class of the Tongji University Medical College with the first place.

To this day, when he opened his resume, no one couldn't help feeling "young and young."

"Most of them are not geniuses, but they depend on their own efforts." Qi Xiaolong laughed. His English -level 46 exams were "over -the -line", and English listening and speaking ability was not outstanding.

Because he "forced himself" during his studies at Harvard University, he has the ability to communicate English today.

In the biological Olympic competition in high school, Qi Xiaolong revealed his talent and interest in life sciences, which also achieved the "fate" of his clinical medicine major in the future.

During college, on many silent nights, Qi Xiaolong might fight hard in the laboratory or browse the literature in the self -study room overnight.

Before each class, he always finished himself in advance, and then listened to the class with questions. During the class, he took the initiative to ask the teacher to answer questions.

In 2009, during the Specialty of the Internal Medicine of Tongji Hospital affiliated to Tongji University, Qi Xiaolong noticed a detail. For the high -incidence and high mortality, the hepatic hardening door vein hypertension had obvious lag in clinical diagnosis.

After reading and reading the literature in an all -round way, he took the initiative to find Yang Changqing, then the director of the digestive department, and put forward his conjecture and research assumptions on this "blank field". Yang Changqing supported him very much and gave patient guidance.

"For a long time, I am very grateful to Teacher Yang Changqing for their support for those immature thoughts during my student." Qi Xiaolong said. Today, he has also become a doctoral supervisor. While doing medical research, he must also educate and guide students. He is very cherished today's teaching work. No matter where you are, as long as you reach the class time, you will definitely "fly back" on time.

Many people will play to recruit, and Qi Xiaolong does not seem to be interested in these. He said that everyone's "excitement" is different, and medical research is the best thing to excite him. "You can see the clinical research you are responsible for progressing smoothly every day. This is the thing that makes me sleep the most."

The international stage is "emerging"

In 2013, Qi Xiaolong was invited to make verbal reports at the International Gastrointestinal Forum, and there were scholars from Australia, Singapore, Japan, South Korea and other places on the same stage, among which well -known experts in this field.

With the high academic value and high English display level, the organizing committee unanimously identified that the only "young scholars' award" was awarded Qi Xiaolong, who was still undergraduate at the time. This is also the first time he has boarded the podium in the international academic field.

During the PhD, with the intersection of research and discipline, Qi Xiaolong was invited to conduct verbal reports at the top international academic conferences such as the annual meeting of the American Liver Disease Research Society and the annual meeting of the European Liver Disease Research Society, which effectively promoted my country, Europe, America, and Asia -Pacific. The academic cooperation of the country in the field of door vein high pressure issued a "Chinese voice".

In 2016, under the initiative of Qi Xiaolong, a number of collaborators of many liver disease centers in my country jointly formed the "Chess (door vein high pressure diagnosis and monitoring research group)", and the first internationally proposed "three -dimensional digital models and fluid mechanics based on three -dimensional digital models and fluid mechanics Calculated virtual hepatic vein pressure gradient technology "" non -invasive liver vein pressure gradient technology based on artificial intelligence and imaging group ".

Over the years, Qi Xiaolong has been full of passion and exploration for door vein high pressure. With his love for this field, he was fortunate to have met a group of like -minded "forgetful year friends" and collaborators.

In 2019, Qi Xiaolong returned to Lanzhou 12 years after leaving his hometown to focus on clinical medical research. At that time, the Chess platform created by Qi Xiaolong was relatively mature.

With the support of Dong Jiahong, an academician of the Chinese Academy of Engineering and Dean of the School of Clinical Medicine of Tsinghua University, Chess further developed.

In December 2021, Qi Xiaolong's team began to prepare for the official English journal Portal Hypertension Cirrhosis, which aims to create a world -class door vein high pressure and liver cirrhosis academic sharing platform, publish high -quality scientific papers and consensus guidelines to the world's medical workers in this field Scientific researchers provide new progress and achievements.

The work was strongly supported by the Chinese Medical Association magazine, Wiley, and the National Infectious Disease Medical Center.

In June 2022, Qi Xiaolong and Teng Junjun, an academician of the Chinese Academy of Sciences and the dean of the University of Southeast University, jointly unveiled the Portal Hypertension Cirrhosis, and its first papers were released worldwide.

This is undoubtedly a milestone in the field of gates and global venous hypertension and cirrhosis. Make a Chinese voice of "Early diagnosis and early treatment"

Busy is the norm of Qi Xiaolong. The place where Qi Xiaolong ran was not just first- and second -tier cities, but also third- and fourth -tier cities, county -level cities, and even townships.

"The basics of going to the large hospital to see a doctor have reached the middle and late stages of the gate venous high pressure. If you want to observe the progress of the disease, you must go to the grass -roots hospitals to understand it." Qi Xiaolong said, "Clinical research should start with the thinking of clinical issues, and finally clinically Practice optimization. Therefore, if you want to design a clinical study, you must understand the current clinical practice, which requires a lot of time to investigate. "

In 2020, the global new crown pneumonia's epidemic spread. Qi Xiaolong led Chess to quickly form a scientific research tackling team. For the first time in the world, the clinical prognosis of patients with cirrhosis combined with new crown pneumonia was reported. As the only academic organization in China, it participated in the world International studies jointly carried out in 29 countries and regions.

Subsequently, he also led the formulation of my country's first "Consensus on the Management Expert Management Expert in the Penal Hypertension of the Penal Hypertension after the Extraction of the Extraction of Coronary Virus Pneumonia".

In 2021, with the promotion of the new crown vaccine, Qi Xiaolong once again led the Chess team to report the safety and effectiveness of the new crown vaccination for chronic liver diseases for the first time in the world.

In the major scientific field of vein hypertension of liver cirrhosis, Qi Xiaolong's team grinded a sword for 12 years and explored a development trajectory with "early screening and early diagnosis and early treatment" as the core. Consensus (2018 Edition).

Subsequently, in 2019, it started to promote the establishment of the vein high -pressure alliance at the provincial and municipal levels. At present, the control system of the alliance has covered more than 500 hospitals across the country.

The vein hypertension is an important factor affecting the clinical prognosis of the world's 120 million liver sclerosis people, bringing a heavy disease burden and economic burden on the patient's family and society.

China is the country with the heaviest burden on liver diseases in the world. More than 400 million patients with chronic liver disease may progress as the hypertension of hepatic cirrhosis.

As the chairman of the Variety and High pressure Professional Committee of the China Human Health and Technology Promotion Association, Qi Xiaolong led the team to focus on this major disease.

"One of the important things in life is to find a group of people you like and to do a valuable thing." Qi Xiaolong said, "I am glad to have encountered the high pressure of the door vein in the early days of my life. In the past 12 years, I have been Fortunately to work hard. "

not

"China Science News" (2022-09-01 The 4th edition of the character original title "Qi Xiaolong: My" Excited Point "in Medical Scientific Research")

not

Edit | Zhao Lu

Capture | Guo Gang

Please press the QR code below for 3 seconds to identify

- END -